Cirio Advokatbyrå AB houses a team which is noted for its ‘large and in-depth‘ knowledge of the life sciences sector. The group handles a wide variety of mandates involving market access, rights issuances of shares, and trade mark mandates concerning parallel imports. Practice head Per Hedman utilises his vast regulatory knowledge to advise international pharma, medtech and biotech companies and investment entities. Praised for her specialism in personal data protection which makes her ‘unique within the Swedish market‘, Hanna Tilus is known for advising on technology transfers, co-marketing issues, and R&D collaborations.

Mannheimer Swartling houses a ‘highly skilled‘ practice, which acts for a diverse client base of medical device manufacturers, domestic and global pharma companies, and innovation focused healthcare providers. The ‘superb‘ Camilla Appelgren leads the team, and is well known for advising on a range of regulatory matters, including cases against national agencies concerning pricing and reimbursement, market access, and clinical trials. ‘Very wise adviser‘ Peter Nilsson Torres has notable knowledge surrounding trial subject data issues and research projects, having assisted numerous healthcare and pharma clients. Emmie Montgomery is particularly adept at advising clients on the processing of patient data, in addition to advertisement-related issues.

Rated by clients as being ‘in a league of its own‘, Setterwalls maintains its stellar reputation for handling the full spectrum of mandates for diagnostic companies, drug distributors, and medical device clients. The group exhibits broad expertise in M&A, licensing and supply agreements, and disputes concerning generics and biosimilars. Leading the practice out of the Malmö office, Per Lidman is known for his longstanding IP expertise, regularly acting for pharma and medtech clients in patent disputes. Martin Levinsohn maintains an IP and competition-focused practice, with his caseload including market exclusivity and marketing-related issues within life sciences. Regulatory specialist Helena Nilsson is well-versed in mandates involving clinical studies, and classification and distribution issues.

Advokatfirman Vinge houses a ‘highly skilled‘ team which is well-known for its expertise in patent disputes concerning royalty agreements, patent assignments, and supplementary protection certificates (SPC). The group frequently assists global pharma and biotech companies, healthcare corporates and investment funds within the life sciences and consumer health sectors. The ‘exceptional‘ Stojan Arnerstål leads the team, and maintains a transaction-focused practice, advising on a range of manufacturing, commercialisation and development agreements within the pharma space. Noted for the ‘unrivalled depth‘ of his knowledge, Håkan Borgenhäll is an IP specialist who has notable experience in handling contentious matters involving registered designs, marketing issues and trade marks.

The ‘experienced and skilled‘ team at Advokatfirman Delphi acts for numerous pharma, medtech, and healthcare companies with a strong focus on innovation. Primarily based in Stockholm, the group has experienced growth in its workload with regard to regulatory advice on medical devices, and healthcare compliance. Practice head Elisabeth Eklund maintains a life sciences regulatory and competition-focused practice, with her primary area of focus being pricing and reimbursement cases, and distribution issues. Malmö’s Micael Karlsson regularly assists clients with corporate social responsibility issues, IPOs, and licensing matters. Public procurement specialist Martin Bogg regularly advises on the interpretation of government contracts, and the execution of public procurements.

The group at Advokatfirman Cederquist KB handles the full spectrum of matters concerning ethical codes and contracts with regulatory authorities within the life sciences and healthcare sector. Malin Allard and Annika Blomqvist jointly head up the practice. Allard is known for her longstanding IP expertise, with technology licensing agreements, strategic IP rights protection, and infringement actions being her main areas of focus. Blomqvist leads the public procurement practice at the firm, advising on distribution agreements, collaboration agreements with healthcare professionals, and clinical study commercial contracts. Dispute resolution expert Elsa Arbrandt acts in international arbitrations and regulatory disputes concerning clinical trials, in addition to advising on internal investigations.

Westerberg & Partners‘ practice frequently assists pharma clients with product launches within the Swedish market. In addition to the group’s extensive contentious IP capability, it also regularly advises on research and development agreements. ‘Excellent‘ patent litigator Jonas Löfgren leads the team with his deep regulatory expertise, with particular emphasis on market access, and pricing and reimbursement matters. Wendela Hårdemark is well-versed in contentious matters concerning license agreements. Ludvig Holm regularly acts in patent and trade mark disputes, while Jonas Westerberg is noted for his vast knowledge of IP litigation and arbitration.

The ‘outstanding‘ Malin von Heideken leads the team at Hammarskiöld, which handles a vast range of issues for its varied client base of generics manufacturers, parallel traders and pharma companies. The practice is well versed in non-contentious matters, including the drafting and negotiation of license and R&D agreements. Von Heideken is noted for her broad experience in representing clients before the Swedish administrative courts in commercial cases against government agencies. Sofia Falkner has a great deal of regulatory expertise, with her primary areas of focus being the pharma and medtech sectors. Falkner also has deep knowledge of Swedish and EU competition law, advising on a number of cartel investigations and the management of internal investigations.

Advokatfirman Lindahl KB houses a group known for its ‘strong and deep‘ knowledge of the sector, regularly assisting start-ups and venture capital backed companies, in addition to international players in the pharma industry. Praised for his ‘excellent‘ industry knowledge, Hugo Norlén leads the Uppsala-based team with his longstanding expertise in strategic collaborations and technology transfers within the pharma, medtech and biotech spaces. Gunnar Mattsson is noted for his broad expertise in corporate and international contractual matters, acting for a number of public and private life sciences companies, while Mikael Smedeby regularly handles issues concerning M&A and licensing transactions.

Possessing ‘undeniable‘ expertise, the team at Magnusson Sweden is known for its expansive experience in public procurement work, with particular emphasis placed on patient safety and workflows, in addition to advising on commercial matters relating to the public sector. ‘Great‘ practice head Morvarid Dorkhan Nilsson regularly assists clients with a broad range of mandates, including the negotiation and drafting of manufacturing agreements, internal ethical guidelines, and permittable modifications to public procurement contracts. Helena Rönqvist maintains an IP and marketing focused practice, handling numerous commercial and IT agreements, while Wille Steinert is noted for his expertise in supply chains and the implementation of international policies and regulatory requirements.

Noted by clients for its ‘precision and skills‘, the team at Roschier is known for handling a variety of matters for its varied client base of innovation focused digital healthcare and pharma companies. Erik Ficks heads up the practice, and has broad experience in advising on transactional matters, including share acquisitions, in addition to acting in patent infringement actions in the pharma space. Björn Johansson Heigis leads the firm’s data protection and digitalisation practice, and is well versed in handling GDPR-related issues concerning medical devices, and research and development matters.

DLA Piper Sweden leverages its international network to advise its broad client base on pricing and reimbursement issues. Practice head Fredrika Allard is noted for her specialism in regulation governing the marketing of pharmaceuticals and collaborations between health professionals within the pharma industry, while competition specialist Erik Brändt Öfverholm has deep knowledge of domestic merger control mandates. Jennie Nilsson leads the firm’s digital, data and cyber group, regularly handling GDPR management projects and issues concerning transparency obligations and intra-group data transfers between companies.

The ‘fantastic‘ team at TM & Partners handles the full gamut of work relating to employment, commercial transactions, and compliance issues. Practice co-head Fredrik Gustafsson is an IT specialist who advises on IT procurements and strategic outsourcing mandates, while co-head Anna Jerndorf is known for her employment expertise. Equity capital markets expert Johan Wigh handles a wide variety of transactional matters, including the offering of preference shares and M&A transactions.